Iontocaine
Chemical compound
- US: Approved in 1995, discontinued in 2005
- 54958-67-7 Y
- DTXSID10970306
Iontocaine was an anesthetic medication, marketed under the two brand names Numby and Phoresor PM900 by IOMED inc. It is a local anesthetic with vasoconstrictor, administered via iontophoresis through the skin. It can numb up to 10 mm of skin in as little as 10 minutes. It is a 2% lidocaine, 0.01 mg/ml epinephrine solution. It was manufactured by IOMED, Inc.
Iontocaine was approved by the United States Food and Drug Administration on 21 December 1995.[1] It was discontinued by the manufacturer in 2005.[2]
References
External links
- IOMED Numby web page from the Internet Archive
- Iontocaine Package Insert from the Internet Archive
- FDA page on iontocaine
- v
- t
- e
Local anesthetics (primarily sodium channel blockers) (N01B)
Aminobenzoic |
|
---|---|
Benzoic | |
ArCO2- (not para-amino or Ph) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e